Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Science Applications Intl Expects FY25 Revenue of $7.35B-$7.50B (Prior $7.25B-$7.40B) Vs $7.36B Est, Reiterated Adj EPS of $8.00-$8.20 Vs $8.15 Est

Author: Benzinga Newsdesk | March 18, 2024 07:05am

Fiscal Year 2025 Guidance

The Company's outlook for fiscal year 2025 is being provided. The table below summarizes fiscal year 2025 guidance and represents our views as of March 18, 2024.

 

PRIOR

CURRENT

 

Fiscal Year

Fiscal Year

 

2025 Guidance

2025 Guidance

Revenue

$7.25B - $7.40B

$7.35B - $7.50B

Adjusted EBITDA(1)

-

$680M - $700M

Adjusted EBITDA Margin %(1)

9.4% - 9.6%

9.2% - 9.4%

Adjusted Diluted EPS(1)

$8.00 - $8.20

$8.00 - $8.20

Free Cash Flow(1)

$480M - $500M

$490M - $510M

Posted In: SAIC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist